| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $455K | -95.4% |
| R&D Expense | $48.7M | -9.6% |
| SG&A Expense | $56.0M | +171.6% |
| Operating Income | -$104.3M | -61.6% |
| Net Income | -$105.6M | +11.8% |
| EPS (Basic) | -$0.76 | +46.5% |
| EPS (Diluted) | -$0.76 | +46.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.4M | +59.1% |
| Current Assets | $83.6M | +53.8% |
| Total Assets | $86.7M | +58.1% |
| Current Liabilities | $27.3M | -61.7% |
| Total Liabilities | $29.7M | -58.8% |
| Stockholders' Equity | $57.0M | +432.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$84.3M | -52.8% |
| Investing Cash Flow | $13.9M | +0.0% |
| Financing Cash Flow | $113.8M | +52.7% |